RE:RE:RE:RE:RE:RE:Second Mysterious Formulation of Avenanthramide:"The problem is there was no ownership of the failure. There was no post study debrief and thus there was no learning. Gilles literally called it a bump in the road and spent zero time communicatiing what went wrong who was to blame and how things could be done better."
He said the pill trial was a failure and moved on. He talked about certain data. It was a bump in the road. The cost was minimal. CZO has more cash than ever and no debt. It has others pipeline assets of more immediate interest given the potential. The stock is at the same price. You supported the beta glucan trial. Take ownership of your loss. The trial didn't work. That's part of science. The trial was worth the risk given the upside. Other information was gained from the pill he said; but you don't lay everything out for the rest of the world to take advantage of. CZO could come back to the pill later. It has other immediate priorities.